UK-CAB 75: Meeting with Gilead Sciences

Thursday 25 November 2020

• Registration
• Meeting on  Zoom – details to follow

Programme

09.25 – Zoom meeting open
09.30-10.00 – Gilead pre-meeting
10.00-11.30  – Gilead company meeting
11.30-11.45 – UK-CAB internal meeting

Slides and meeting report

to follow

Background reading

to follow

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year.

This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering. The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.